Full Breakdown
Antidepressant Use in the United States: Racial Gaps, Treatment Gaps, and Suicide Prevention
5/18/2026, 8:48:45 PM
Prevalence
A 2024 survey found that over 16 percent of U.S. adults reported using antidepressants. Use was notably lower among Black, Hispanic, and Asian adults than non-Hispanic white adults.
Treatment Gaps
From 2021-2023, only about 40 percent of adolescents and adults with depression received counseling or therapy. Black and Hispanic Americans were less likely to obtain treatment and faced longer medication delays.
Recurrence and Suicide
Clinical data show that 50 percent of people with a single depressive episode avoid recurrence, while a second episode raises the chance of a third to 70 percent and a fourth to 90 percent. In 2023, suicide ranked as the 11th leading cause of death in the United States and the second among ages 10-34.
Expert Perspective
Psychiatrist Dr. Rappaport noted that earlier antidepressants were harder to use and had more side effects. He called SSRIs and SNRIs a “godsend” for safety and ease, saying long-term use is unnecessary for most, though severe depression may need sustained treatment.
Historical Context
Before the advent of modern antidepressants such as SSRIs and SNRIs, the medications available for mental disorders required more complex dosing and were associated with higher side-effect burdens, limiting their tolerability for many patients.
Official Statements
The World Health Organization lists depression as the leading cause of global disability, and U.S. health data show suicide as the 11th leading cause of death overall in 2023 and the second among ages 10-34, underscoring the need for integrated mental-health services worldwide and age-specific suicide-prevention priorities.
Why It Matters
Racial gaps in antidepressant use and broader treatment access deepen mental-health inequities, raising the risk of recurrent depression and suicide among underserved groups. Closing these gaps is essential for achieving equitable public-health outcomes. The recurrence data show that individuals with multiple depressive episodes face a high likelihood of further episodes.
Verbatim Quotes
- “By comparison, SSRIs and SNRIs have been a “godsend,” Rappaport continued, because of their safety and ease of use.”.” — Dr. Rappaport, Psychiatrist
- “This does not mean that everyone who uses antidepressants needs to be on them for an extended period of time, he continued, but for those with severe depression, it can offer life-saving stability.” — Dr. Rappaport, Psychiatrist
- “When Rappaport began practicing as a psychiatrist, modern antidepressants did not yet exist; the medications for treating mental disorders at the time were, according to his recollection, more difficult to use and had greater side effects.” — Dr. Rappaport, Psychiatrist
- “However, for those who do see a second episode, they are 70 percent more likely to see a third, and 90 percent more likely to see another afterwards.” — Dr. Rappaport, Psychiatrist
